Showing results (1-10 of 1,359) with videos related to
Sort By:
Pageof 136
Tidsskrift for Den Norske Laegeforening : Tidsskrift for Praktisk Medicin, Ny Raekke|February 28, 1992
[Prognostic parameters in localized breast cancer]W Reed, S Gundersen, P E Lønning, et al.Acta Oncologica (Stockholm, Sweden)|September 22, 1998
Influence of droloxifene on metastatic breast cancer as first-line endocrine treatmentH Haarstad, P E Lønning, S Gundersen, et al.Breast Cancer Research and Treatment|November 1, 1989
Megestrol acetate versus aminoglutethimide for metastatic breast cancerS Lundgren, S Gundersen, R Klepp, et al.The Journal of Endocrinology|August 1, 1995
Influence of treatment with the anti-oestrogen 3-hydroxytamoxifen (droloxifene) on plasma sex hormone levels in postmenopausal patients with breast cancerJ Geisler, H Haarstad, S Gundersen, et al.Anticancer Research|March 1, 1994
Simple mucins (T, sialosyl-T, Tn and sialosyl-Tn) are not diagnostic for malignant breast lesionsW Reed, M Bryne, H Clausen, et al.Virchows Archiv : an International Journal of Pathology|December 22, 1999
Elevated levels of p27, p21 and cyclin D1 correlate with positive oestrogen and progesterone receptor status in node-negative breast carcinoma patientsW Reed, V A Flørems, R Holm, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 10, 2010
The potency and clinical efficacy of aromatase inhibitors across the breast cancer continuumP E LønningThe Journal of Steroid Biochemistry and Molecular Biology|February 19, 2002
Stepwise estrogen suppression manipulating the estrostatP E LønningEuropean Journal of Cancer (Oxford, England : 1990)|December 9, 2008
Lack of complete cross-resistance between different aromatase inhibitors; a real finding in search for an explanation?P E LønningActa Oncologica (Stockholm, Sweden)|January 1, 1990
New endocrine drugs for treatment of advanced breast cancerP E LønningPageof 136